Faron Pharmaceuticals Oy (FARN) News Today

GBX 260

-5.00 (-1.89%)

(As of 11/28/2023 09:22 PM ET)

Compare

Today's Range: 248
▼
260
50-Day Range: 251
▼
350
52-Week Range: 218.86
▼
395

Volume: 2,500 shs
Average Volume: 9,521 shs
Market Capitalization: £178.85 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Headlines

Source

Source	Headline
	Faron Pharmaceuticals Oy FARN morningstar.com - November 24 at 1:03 PM
	Faron Pharmaceuticals initiates second phase of BEXMAB study finance.yahoo.com - November 6 at 1:27 PM
	Faron Pharmaceuticals Oy's (LON:FARN) last week's 11% decline must have disappointed individual investors who have a significant stake finance.yahoo.com - November 6 at 8:26 AM
	Faron to Present Phase 1/2 Data From BEXMAB Study of Bexmarilimab in Combination with Standard of Care in Myeloid Malignancies at the 65th American Society of Hematology Annual Meeting finance.yahoo.com - November 2 at 10:22 AM
	Faron Pharma raises €7.1m as cancer study continues apace proactiveinvestors.com - October 27 at 10:32 AM
	Inside Information: Announcement of the Results of Placing, the Issue Price and registration of Placing Shares with the Trade Register finance.yahoo.com - October 27 at 10:32 AM
	Faron Pharmaceuticals' chief speaks after latest promising BEXMAB trial data proactiveinvestors.com - October 16 at 10:00 AM
	Faron Pharma data 'extremely encouraging', says CEO proactiveinvestors.com - October 11 at 1:53 PM
	Faron Pharmaceuticals data 'highly encouraging', say bank proactiveinvestors.com - October 11 at 8:00 AM
	Inside information: Faron Announces Positive BEXMAB Study Update in Relapsed/Refractory AML and HMA-Refractory MDS Patients finance.yahoo.com - October 11 at 8:00 AM
	Faron to Host Webcast to Discuss New Data From Phase I/II BEXMAB Study of Bexmarilimab and Provide Update on the Development Outlook for Next 6-9 Months finance.yahoo.com - October 3 at 9:20 AM
	Breakeven On The Horizon For Faron Pharmaceuticals Oy (LON:FARN) finance.yahoo.com - September 26 at 8:14 AM
	Faron Pharmaceuticals Ltd Results of the Extraordinary General Meeting markets.businessinsider.com - September 22 at 10:15 PM
	Faron Pharmaceuticals Announces Board Changes finance.yahoo.com - September 22 at 12:14 PM
	Faron Pharmaceuticals Ltd Results of the Extraordinary General Meeting finance.yahoo.com - September 22 at 7:14 AM
	BRIEF-Faron Pharmaceuticals Appoints Birge Berns As Interim Chief Medical Officer reuters.com - September 21 at 7:24 AM
	Faron Pharma appoints new chief medical officer proactiveinvestors.com - September 21 at 7:24 AM
	Faron Pharmaceuticals Oy: Faron Appoints Dr. Birge Berns, MD as Interim Chief Medical Officer finanznachrichten.de - September 21 at 7:24 AM
	Faron Appoints Dr. Birge Berns, MD as Interim Chief Medical Officer finance.yahoo.com - September 21 at 2:24 AM
	Faron Pharmaceuticals Ltd. to Present at the H.C. Wainwright 25th Annual Global Investment Conference finance.yahoo.com - September 6 at 3:54 AM
	Faron Pharmaceuticals kicks off second half with FDA announcement finance.yahoo.com - September 1 at 8:44 AM
	Faron Pharmaceuticals Oy's (LON:FARN) Intrinsic Value Is Potentially 98% Above Its Share Price finance.yahoo.com - August 30 at 6:26 AM
	Faron Pharmaceuticals Oy: Faron Receives FDA Orphan Drug Designation for Bexmarilimab in Acute Myeloid Leukemia finanznachrichten.de - August 29 at 5:20 AM
	Faron Receives FDA Orphan Drug Designation for Bexmarilimab in Acute Myeloid Leukemia finance.yahoo.com - August 29 at 12:20 AM
	Faron Reports Half-Year Financial Results, January 1 – June 30, 2023 finance.yahoo.com - August 29 at 12:20 AM
	Faron Pharmaceuticals Notice of Half-Year Financial Results finance.yahoo.com - August 4 at 4:49 PM
	Faron to Participate in Fireside Chat at the Canaccord Genuity 43rd Annual Growth Conference finance.yahoo.com - August 2 at 12:02 PM
	Faron Pharmaceuticals hoping for first filing of BLA in H1 2025 finance.yahoo.com - July 25 at 8:45 AM
	Faron Updates Positive Clinical Data from Phase I/II BEXMAB Study of Bexmarilimab in Relapsed/Refractory AML and MDS BEXMAB Study Update finance.yahoo.com - July 19 at 8:32 AM
	Faron to Hold Conference Call to Discuss New Positive Clinical Data from Phase I/II BEXMAB Study of Bexmarilimab in Relapsed/Refractory AML and MDS finance.yahoo.com - July 19 at 8:32 AM
	FARON.HE - Faron Pharmaceuticals Oy uk.finance.yahoo.com - June 21 at 6:34 PM
	New biomarker data from BEXMAB study at EHA2023 finance.yahoo.com - June 9 at 4:16 AM
	Faron Pharmaceuticals non-exec takes front line role negotiating potential partnerships for key cancer drug proactiveinvestors.com - June 5 at 7:52 AM
	Faron Pharmaceuticals non-exec takes front line role negotiating potential partnerships for co's key cancer drug proactiveinvestors.com - June 5 at 7:52 AM
	Faron Pharmaceuticals Oy's (LON:FARN) top owners are individual investors with 49% stake, while 35% is held by insiders finance.yahoo.com - May 16 at 9:05 AM
	Faron Pharmaceuticals "confirms promising results from first cohort" proactiveinvestors.com - April 20 at 8:15 AM
	Faron Pharma to host virtual event on progress in novel immunotherapies development proactiveinvestors.com - April 19 at 3:37 PM
	Faron Pharma plans to host virtual event on progress in novel immunotherapies development proactiveinvestors.com - April 19 at 10:36 AM
	When Will Faron Pharmaceuticals Oy (LON:FARN) Breakeven? finance.yahoo.com - April 19 at 10:36 AM
	Faron Pharma makes two presentations at US cancer conference proactiveinvestors.com - April 18 at 8:48 AM
	Faron Pharma: Broker heartened by latest data release proactiveinvestors.com - April 17 at 3:26 PM
	Faron Pharma releases encouraging additional data on cancer drug proactiveinvestors.com - April 17 at 7:37 AM
	Faron Pharmaceuticals moving "into next phase" with new CFO proactiveinvestors.com - April 5 at 10:46 AM
	Faron Pharma appoints James O'Brien as new CFO proactiveinvestors.com - March 29 at 10:02 AM
	Faron Pharmaceuticals Oy's (LON:FARN) Intrinsic Value Is Potentially 19% Below Its Share Price finance.yahoo.com - March 14 at 4:02 AM
	Faron Pharmaceuticals CMO "looking forward to a year filled with good data for the patients" finance.yahoo.com - February 16 at 10:55 AM
	Faron Pharmaceuticals raises €12mln to fast-track cancer drug proactiveinvestors.com - January 27 at 7:38 AM
	Faron Pharma hails 'promising' early cancer data proactiveinvestors.com - January 16 at 9:55 AM
	Faron Pharmaceuticals Oy (FARON.HE) finance.yahoo.com - January 7 at 3:03 PM
	Faron Pharmaceuticals rallies on strong trial results proactiveinvestors.com - December 7 at 6:17 PM

Get Faron Pharmaceuticals Oy News Delivered to You Automatically

FARN Media Mentions By Week

FARN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

FARN
News Sentiment
▼
0.00

0.80
▲
Average
Medical
News Sentiment

FARN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

FARN Articles
This Week
▼
1

1
▲
FARN Articles
Average Week

Get Faron Pharmaceuticals Oy News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (LON:FARN) was last updated on 11/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Faron Pharmaceuticals Oy (FARN) News Today

FARN Media Mentions By Week

FARN Media Sentiment

FARN News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info